The prevalence of BK polyomavirus infection in outpatient kidney transplant recipients followed in a single center

Clinical Transplantation

Volumn 22, Issue 5, 2008, Pages 532-541

  Yeo, Fred E ^a   Yuan, Christina M ^a   Swanson, Sydney J ^a   Reinmuth, Bruce ^a   Kiandoli, Luana C ^a   Kaplan, Keith J ^b   Abbott, Kevin C ^a   Reynolds, Joel C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIDOFOVIR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BK VIRUS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; DRUG DOSE REDUCTION; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNIVARIATE ANALYSIS; URINALYSIS; URINE CYTOLOGY; VIREMIA;

ADULT; AGED; BK VIRUS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; TUMOR VIRUS INFECTIONS; URINALYSIS; VIREMIA; VIRUS SHEDDING;

EID: 52649153558     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00817.x     Document Type: Article

References (23)

1. Hirsch HH. Polyomavirus BK nephropathy: A (re-) emerging complication in renal transplantation. Am J Transplant 2002: 2: 25.
2. Binet I, Nickeleit V, Hirsch HH et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999: 67: 918.
3. Kazory A, Ducloux D. Renal transplantation and polyomavirus infection: recent clinical facts and controversies. Transpl Infect Dis 2003: 5: 65.
4. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002: 347: 488.
5. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002: 13: 2145.
6. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971: 1: 1253.
7. Mengel M, Marwedel M, Radermacher J et al. Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003: 18: 1190.
8. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973: 128: 784.
9. Chesters PM, Heritage J, Mc Cance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983: 147: 676.
10. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: An emerging syndrome. Transplantation 2001: 72: 1587.
11. Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000: 342: 1309.
12. Koss L. Diagnostic Cytology and Its Histopathologic Bases, 4th edn. Philadelphia, PA: Lippincott, 1992.
13. Nickeleit V, Hirsch HH, Binet IF et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999: 10: 1080.
14. Drachenberg CB, Beskow CO, Cangro CB et al. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Hum Pathol 1999: 30: 970.
15. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003: 3: 611.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999: 130: 461.
17. Vats A, Shapiro R, Singh Randhawa P et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003: 75: 105.
18. Nickeleit V, Hirsch HH, Zeiler M et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000: 15: 324.
19. Mayr M, Nickeleit V, Hirsch HH, Dickenmann M, Mihatsch MJ, Steiger J. Polyomavirus BK nephropathy in a kidney transplant recipient: Critical issues of diagnosis and management. Am J Kidney Dis 2001: 38: E13.
20. Stilmant MM, Freedlund MC, Schmitt GW. Cytologic evaluation of urine after kidney transplantation. Acta Cytol 1987: 31: 625.
21. Trofe J, Gaber LW, Stratta RJ et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003: 5: 21.
22. Hodur DM, Mandelbrot D. Immunosuppression and BKV nephropathy. N Engl J Med 2002; 347: 2079 (author reply 2079).
23. Trofe J. Early steroid cessation-avoidance regimens are associated with a lower incidence of polyomavirus nephropathy compared with steroid-based immunosuppression in kidney transplant recipients. Transplantation Reviews 2003: 17: S52.